Eli Lilly and Company(LLY) Q3
EPS: 7.48 USD; Forecast 5.68 USD
Revenue: 24.4B USD; Forecast 22.58B USD
Reporting period: 2026 Q3 (period ended 2026-09-30)
Release date: 2026-10-29